Wen Qi, Yang Ronghua, Luo Qin, Shi Qiangqiang, Chen Ze, Gao Chen, Du Haijun, Mei Guoyong, Li Shuying, Song QinQin, Han Jun
National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Hebei Key Laboratory for Chronic Disease, College of Basic Medicine, North China University of Science and Technology, Tangshan, China.
Front Public Health. 2025 Apr 7;13:1548907. doi: 10.3389/fpubh.2025.1548907. eCollection 2025.
To investigate the epidemiological characteristics and genetic profile of human bocavirus (HBoV) among patients with acute respiratory infection (ARI) in Yucheng, Henan, China.
A total of 1,153 throat swabs were collected from ARI patients between March and June 2023. These samples were tested for 18 pathogens using quantitative chain reaction (qPCR). The VP1 gene were amplified and sequenced from HBoV-positive samples. The viral genetic characterization was analyzed by comparing the HBoV1 sequences with reference sequences.
Of the 1,153 samples, the detection rate of HBoV positive was 6.85%, primarily detected in May 2023. The majority of HBoV positive cases were found in children under 5 years old. Clinical manifestations in HBoV-positive patients predominantly were fever and cough, with a clinical diagnosis of lower respiratory tract infection. Other viruses were also detected in 20% of HBoV-positive samples. All HBoV sequences identified in this study belonged to HBoV1, with the Ib sublineage being the predominant strain circulating in Yucheng during March-June 2023.
After the implementation of the optimized COVID-19 prevention and control strategy in December 2022, HBoV infection was prevalent in Yucheng, Henan in May-June 2023, mainly among children younger than 5 years old, especially those under 2 years old. The Ib sublineage of HBoV was the dominant circulating strain in Yucheng, Henan during March-June 2023.
调查中国河南省虞城县急性呼吸道感染(ARI)患者中人类博卡病毒(HBoV)的流行病学特征和基因特征。
于2023年3月至6月期间,从ARI患者中收集了总共1153份咽拭子。使用定量链反应(qPCR)对这些样本进行18种病原体检测。对HBoV阳性样本的VP1基因进行扩增和测序。通过将HBoV1序列与参考序列进行比较来分析病毒基因特征。
在1153份样本中,HBoV阳性检出率为6.85%,主要在2023年5月检出。大多数HBoV阳性病例见于5岁以下儿童。HBoV阳性患者的临床表现主要为发热和咳嗽,临床诊断为下呼吸道感染。在20%的HBoV阳性样本中还检测到了其他病毒。本研究中鉴定的所有HBoV序列均属于HBoV1,其中Ib亚系是2023年3月至6月期间在虞城县流行的主要毒株。
在2022年12月实施优化的新冠疫情防控策略后,2023年5月至6月期间HBoV感染在河南虞城县流行,主要发生在5岁以下儿童,尤其是2岁以下儿童。HBoV的Ib亚系是2023年3月至6月期间河南虞城县的主要流行毒株。